John Abeles

John Abeles

Gründer bei
MedVest, Inc.
81 Jahre
Health Technology
Finance
Commercial Services

Profil

John H.
Abeles
founded MedVest, Inc. in 1980, where he is working as President from 2011 and ContraFect Corp.
in 2008, where he worked as Director.
Dr. Abeles also founded Oncolyze, Inc., where he is working as Director.
Dr. Abeles also currently works at UniMedica, Inc., as Chairman from 2011, Alison Raffaele Cosmetics, Inc., as Director, CombiMatrix Molecular Diagnostics, Inc., as Director from 1996, Baystar Biosciences, as Director, Medezrin Ltd., as Director, Medisync Midwest LLC, as Director, Higuchi Bioscience Center, as Director from 1997, International Opera Alliance, as Director, OHK Medical Devices, Inc., as Director, Pattern Pharma, Inc., as Director, International University of Health Sciences, as Assistant Professor-Clinical Pharmacology from 2011, Players Club, as Member, and Dalyda Finance LLC, as Managing Member.
Dr. Abeles also formerly worked at I-Flow Corp., as Director from 1985 to 2009, Oryx Technology Corp., as Director, DUSA Pharmaceuticals, Inc., as Director, CytoCore, Inc., as Director from 1999 to 2011, CombiMatrix Corp., as Independent Director in 2012, MEDITE Cancer Diagnostics, Inc., as Independent Director, Neurotrope, Inc., as Director from 2014 to 2015, The New Group, Inc., as Director, GliaMed, Inc., as Director, Etubics Corp., as Director, ReAble Therapeutics, Inc., as Director, Hadean Ventures AS, as Managing Director in 2017, Northlea Partners LLLP, as General Partner, Roberts Mitani LLC, as Advisor, and Kidder Peabody, as Analyst in 1980.
Dr. Abeles received his undergraduate degree and doctorate degree from the University of Birmingham.

Aktive Positionen von John Abeles

UnternehmenPositionBeginn
MedVest, Inc.
Gründer 06.05.2010
Direktor/Vorstandsmitglied -
Corporate Officer/Principal 01.01.1998
UniMedica, Inc.
Vorsitzender 01.01.1998
Baystar Biosciences
Direktor/Vorstandsmitglied -
Medezrin Ltd.
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
CombiMatrix Molecular Diagnostics, Inc.
Direktor/Vorstandsmitglied 01.01.1996
Direktor/Vorstandsmitglied 14.07.2010
░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Ehemalige bekannte Positionen von John Abeles

UnternehmenPositionEnde
░░░░░░ ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von John Abeles im Detail an

Ausbildung von John Abeles

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

60

Beziehungen ersten Grades

33

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen33

Health Technology

Producer Manufacturing

Health Technology

Northlea Partners LLLP

Health Technology

Health Services

Finance

Retail Trade

Health Technology

Commercial Services

Finance

Consumer Services

MedVest, Inc.

Health Technology

CombiMatrix Molecular Diagnostics, Inc.

Health Services

Consumer Services

UniMedica, Inc.

Health Technology

Health Technology

Baystar Biosciences

Medezrin Ltd.

Commercial Services

Health Technology

Higuchi Bioscience Center

Commercial Services

Health Technology

Dalyda Finance LLC

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. John Abeles
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT